SLS
SELLAS Life Sciences Group, Inc. Common StockstockNASDAQ
σellas life sciences is a healthcare-oriented global group of companies with a unique and innovative vision, which is ambitious, yet clear: to practice the medicine of tomorrow, today. in other words, we incorporate innovation throughout all our activities aiming at breakthroughs that will have a significant impact on the thinking and practicing of healthcare worldwide. our international team of acknowledged scientists, doctors and health professionals along with a seasoned and highly experienced pharmaceutical executive management form the core of σellas. we strive to improve patients' quality of life through developing and commercializing cutting-edge drugs, medical devices and innovative therapies.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 8.42 | 2026-11-06 | -6.53% | 2.076 |
| 1M | 12.41 | 2026-10-13 | -36.58% | 2.991 |
| 3M | 12.36 | 2026-08-13 | -36.33% | 2.392 |
| 6M | 6.53 | 2026-05-13 | +20.52% | 2.459 |
| 1Y | 1.46 | 2025-11-13 | +439.04% | 2.267 |
| 2Y | 1.27 | 2024-11-13 | +519.68% | — |
| 5Y | 7.18 | 2021-11-12 | +9.61% | 1.242 |
SELLAS Life Sciences Group, Inc. Common Stock (NASDAQ:SLS) stock price today is $7.87, and today's volume is 11,170,073. SLS is down 1.993% today. The 30 day average volume is 6.63M. SLS market cap is $1.59B with 201.95M shares outstanding.